Additionally, it was observed that MHD patients with cognitive impairment exhibited significantly lower levels of brain-derived neurotrophic factor (BDNF) and platelet counts (PLT) in comparison with both healthy controls and individuals with normal cognitive function. The gene discussed is BDNF; the disease is Cognitive impairment.